Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,490 | 19,330 | 33,310 | 38,150 | 28,560 |
| Marketable Securities | 1,940 | 1,970 | 1,960 | 3,500 | 1,470 |
| Receivables | 100 | 40 | 50 | 270 | 50 |
| Other current assets | 360 | 340 | 740 | 280 | 460 |
| TOTAL | $26,890 | $21,680 | $36,060 | $42,200 | $30,540 |
| Non-Current Assets | |||||
| PPE Net | 510 | 400 | 390 | 220 | 180 |
| Investments And Advances | 0 | 0 | 0 | 0 | 600 |
| Other Non-Current Assets | 0 | 0 | 0 | 710 | 0 |
| TOTAL | $510 | $400 | $390 | $930 | $780 |
| Total Assets | $27,410 | $22,090 | $36,450 | $43,140 | $31,330 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,830 | 7,290 | 6,580 | 2,420 | 3,720 |
| TOTAL | $5,830 | $7,290 | $6,580 | $2,420 | $3,720 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,830 | $7,290 | $6,580 | $2,420 | $3,720 |
| Shareholders' Equity | |||||
| Common Shares | 222,070 | 198,270 | 179,410 | 150,720 | 116,110 |
| Retained earnings | -224,730 | -207,930 | -173,490 | -134,730 | -104,560 |
| Other shareholders' equity | 440 | 310 | 2,560 | 5,890 | 3,970 |
| TOTAL | $21,570 | $14,790 | $29,870 | $40,710 | $27,610 |
| Total Liabilities And Equity | $27,400 | $22,080 | $36,450 | $43,130 | $31,330 |